209 related articles for article (PubMed ID: 28539706)
1. Multiple Immunosuppressive Effects of CpG-c41 on Intracellular TLR-Mediated Inflammation.
Liu W; Yang X; Wang N; Fan S; Zhu Y; Zheng X; Li Y
Mediators Inflamm; 2017; 2017():6541729. PubMed ID: 28539706
[TBL] [Abstract][Full Text] [Related]
2. The early induction of suppressor of cytokine signaling 1 and the downregulation of toll-like receptors 7 and 9 induce tolerance in costimulated macrophages.
Lee HJ; Kim KC; Han JA; Choi SS; Jung YJ
Mol Cells; 2015 Jan; 38(1):26-32. PubMed ID: 25518931
[TBL] [Abstract][Full Text] [Related]
3. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia.
Butchi NB; Du M; Peterson KE
Glia; 2010 Apr; 58(6):650-64. PubMed ID: 19998480
[TBL] [Abstract][Full Text] [Related]
4. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
5. A novel antagonist of TLR9 blocking all classes of immunostimulatory CpG-ODNs.
Li Y; Cao H; Wang N; Xiang Y; Lu Y; Zhao K; Zheng J; Zhou H
Vaccine; 2011 Mar; 29(11):2193-8. PubMed ID: 21036131
[TBL] [Abstract][Full Text] [Related]
6. Synthetic Human TLR9-LRR11 Peptide Attenuates TLR9 Signaling by Binding to and thus Decreasing Internalization of CpG Oligodeoxynucleotides.
Pan X; Li B; Kuang M; Liu X; Cen Y; Qin R; Ding G; Zheng J; Zhou H
Int J Mol Sci; 2016 Feb; 17(2):242. PubMed ID: 26907260
[TBL] [Abstract][Full Text] [Related]
7. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
[TBL] [Abstract][Full Text] [Related]
8. CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding.
Molad Y; Pokroy-Shapira E; Carmon V
Innate Immun; 2013 Dec; 19(6):623-30. PubMed ID: 23475790
[TBL] [Abstract][Full Text] [Related]
9. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
Andersen JM; Al-Khairy D; Ingalls RR
Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
[TBL] [Abstract][Full Text] [Related]
10. Combined TLR7/8 and TLR9 ligands potentiate the activity of a Schistosoma japonicum DNA vaccine.
Wang X; Dong L; Ni H; Zhou S; Xu Z; Hoellwarth JS; Chen X; Zhang R; Chen Q; Liu F; Wang J; Su C
PLoS Negl Trop Dis; 2013; 7(4):e2164. PubMed ID: 23593527
[TBL] [Abstract][Full Text] [Related]
11. Toll like receptor 9 antagonism modulates spinal cord neuronal function and survival: Direct versus astrocyte-mediated mechanisms.
Acioglu C; Mirabelli E; Baykal AT; Ni L; Ratnayake A; Heary RF; Elkabes S
Brain Behav Immun; 2016 Aug; 56():310-24. PubMed ID: 27044334
[TBL] [Abstract][Full Text] [Related]
12. Neu1 sialidase and matrix metalloproteinase-9 cross-talk regulates nucleic acid-induced endosomal TOLL-like receptor-7 and -9 activation, cellular signaling and pro-inflammatory responses.
Abdulkhalek S; Szewczuk MR
Cell Signal; 2013 Nov; 25(11):2093-105. PubMed ID: 23827939
[TBL] [Abstract][Full Text] [Related]
13. Innate immune responses after stimulation with Toll-like receptor agonists in ex vivo microglial cultures and an in vivo model using mice with reduced microglia.
Carroll JA; Race B; Williams K; Striebel JF; Chesebro B
J Neuroinflammation; 2021 Sep; 18(1):194. PubMed ID: 34488805
[TBL] [Abstract][Full Text] [Related]
14. Targeting Suppressive Oligonucleotide to Lymph Nodes Inhibits Toll-like Receptor-9-Mediated Activation of Adaptive Immunity.
Yu C; An M; Jones E; Liu H
Pharm Res; 2018 Feb; 35(3):56. PubMed ID: 29423660
[TBL] [Abstract][Full Text] [Related]
15. Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer.
Moreno Ayala MA; Gottardo MF; Gori MS; Nicola Candia AJ; Caruso C; De Laurentiis A; Imsen M; Klein S; Bal de Kier Joffé E; Salamone G; Castro MG; Seilicovich A; Candolfi M
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1713-1732. PubMed ID: 28432455
[TBL] [Abstract][Full Text] [Related]
16. TLR9 and TLR7/8 activation induces formation of keratic precipitates and giant macrophages in the mouse cornea.
Chinnery HR; Leong CM; Chen W; Forrester JV; McMenamin PG
J Leukoc Biol; 2015 Jan; 97(1):103-10. PubMed ID: 25416814
[TBL] [Abstract][Full Text] [Related]
17. A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation.
Månsson A; Adner M; Höckerfelt U; Cardell LO
Immunology; 2006 Aug; 118(4):539-48. PubMed ID: 16780564
[TBL] [Abstract][Full Text] [Related]
18. TLR9 ligand CpG-ODN applied to the injured mouse cornea elicits retinal inflammation.
Chinnery HR; McLenachan S; Binz N; Sun Y; Forrester JV; Degli-Esposti MA; Pearlman E; McMenamin PG
Am J Pathol; 2012 Jan; 180(1):209-20. PubMed ID: 22085974
[TBL] [Abstract][Full Text] [Related]
19. Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor-9-mediated activation of innate immunity.
Peter M; Bode K; Lipford GB; Eberle F; Heeg K; Dalpke AH
Immunology; 2008 Jan; 123(1):118-28. PubMed ID: 17961163
[TBL] [Abstract][Full Text] [Related]
20. Anti-WASP intrabodies inhibit inflammatory responses induced by Toll-like receptors 3, 7, and 9, in macrophages.
Sakuma C; Sato M; Oshima T; Takenouchi T; Chiba J; Kitani H
Biochem Biophys Res Commun; 2015 Feb; 458(1):28-33. PubMed ID: 25634698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
